Background: Periprosthetic joint infection (PJI) is among the most serious complications following total joint replacement. Biomarkers hold crucial importance in PJI diagnosis. However, their relative diagnostic accuracy has not yet been systematically compared across various established markers. This study comprehensively evaluated the diagnostic accuracy of established serum and synovial fluid biomarkers for PJI through a network meta-analysis (NMA).Methods: A systematic search was conducted in PubMed, Web of Science, Embase, and Cochrane Library from the inception of each database to January 1, 2026. Search terms included “periprosthe*”, “prosthe*”, and terms related to diagnostic accuracy. Two reviewers independently screened the literature, extracted data, and appraised study quality using the QUADAS-2 tool. A NMA based on an ANOVA model was performed using R software (version 4.5.1). The primary outcome measures covered diagnostic odds ratio (DOR), sensitivity, specificity, superiority index (SI), and the surface under the cumulative ranking curve (SUCRA).Result: We ultimately included 335 studies; 321 of these were eligible for a NMA, covering 164,812 participants (of whom 34,301 were diagnosed with PJI). Among serum biomarkers, C-reactive protein (CRP) to albumin ratio (CAR) had the highest DOR (DOR: 30.33, 95% CrI: 18.32–46.05), followed by CRP/albumin-to-globulin ratio (CAGR) (19.84, 8.98–36.54) and CRP (14.05, 12.87–15.30). Overall, the diagnostic efficacy of synovial fluid biomarkers was notably superior to that of serum biomarkers, with Calprotectin (CLP) exhibiting the highest DOR (110.86, 58.36–186.30), followed by neutrophil gelatinase-associated lipocalin (NGAL) (100.28, 27.03–244.29) and alpha-defensin (AD) (73.81, 55.92–95.03). AD (SI: 18.80, 95% CrI: 5.67–27.00), CLP (18.41, 4.33–29.00), and absolute neutrophil count (ANC) (13.14, 1.80–27.00) had greater diagnostic advantage than traditional white blood cell count (WBC) (1.93, 0.64–4.20) and polymorphonuclear neutrophil percentage (PMN%) (1.46, 0.47–3.00). The ranking trend of sensitivity and relative sensitivity aligned with that of DOR and SI. Subgroup analyses revealed that synovial fluid biomarkers performed better in knee PJI than in hip PJI; acute infections predominantly showed elevated ANC and WBC levels, whereas chronic infections predominantly showed elevated CLP and AD levels.Conclusion: Synovial fluid biomarkers (particularly CLP, NGAL, and AD) markedly outperform serum biomarkers in PJI diagnosis, with CAR as the optimal serum biomarker. These findings furnish evidence-based support for tiered selection and integrated testing strategies for clinical biomarkers.